Walleye Trading’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Walleye Trading’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,010	Closed	-$54	–	5017
2017 Q4	$54	Sell	1,010 -5,713	-85%	-$313K	﹤0.01%	4002
2017 Q3	$384	Buy	6,723 +6,278	+1,411%	+$368K	﹤0.01%	2711
2017 Q2	$27	Sell	445 -23,995	-98%	-$1.37M	﹤0.01%	4065
2017 Q1	$1.33K	Buy	+24,440	New	+$1.2M	0.01%	1404

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Walleye Trading's BIVV Position: Q1 2018 in Review

Walleye Trading sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,010 shares — an estimated $54 sold.

Walleye Trading first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.33K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Walleye Trading reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Walleye Trading sold 1,010 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $54.
Walleye Trading first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Walleye Trading's Bioverativ Inc. Common Stock position peaked at $1.33K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Walleye Trading's 13F filing for Q1 2018, filed 15 May 2018.